Company Valuation: Coloplast A/S

Fiscal Period: September 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 175,241 213,422 214,092 164,708 167,956 208,202 - -
Change - 21.79% 0.31% -23.07% 1.97% 23.96% - -
Enterprise Value (EV) 1 175,780 214,584 216,204 182,799 186,616 227,210 226,437 225,122
Change - 22.07% 0.76% -15.45% 2.09% 21.75% -0.34% -0.58%
P/E ratio 45.4x 51x 44.5x 35.1x 33.7x 40.8x 34.8x 30.5x
PBR 25.3x 28.9x 26.2x 19.9x 9.24x 11.7x 10.9x 10x
PEG - 6.22x 3x -15.28x 82.79x 17.36x 2x 2.2x
Capitalization / Revenue 9.77x 11.5x 11x 7.29x 6.86x 7.71x 7.12x 6.57x
EV / Revenue 9.8x 11.6x 11.1x 8.1x 7.62x 8.42x 7.74x 7.1x
EV / EBITDA 28.3x 32x 31.1x 23.3x 23.6x 26.4x 23.4x 21x
EV / EBIT 31.6x 36.7x 34x 26.5x 27.3x 30.8x 27.2x 24.2x
EV / FCF 46.7x 54.8x 49.5x 43.8x 58.2x 40.7x 36.6x 32.1x
FCF Yield 2.14% 1.82% 2.02% 2.28% 1.72% 2.46% 2.74% 3.11%
Dividend per Share 2 17 18 19 20 21 19.99 21.51 23.49
Rate of return 2.06% 1.79% 1.89% 2.58% 2.81% 2.16% 2.32% 2.54%
EPS 2 18.18 19.67 22.63 22.11 22.2 22.72 26.65 30.34
Distribution rate 93.5% 91.5% 84% 90.5% 94.6% 88% 80.7% 77.4%
Net sales 1 17,939 18,544 19,426 22,579 24,500 26,998 29,240 31,698
EBITDA 1 6,207 6,705 6,947 7,840 7,914 8,609 9,668 10,740
EBIT 1 5,556 5,854 6,355 6,910 6,845 7,372 8,323 9,296
Net income 1 3,873 4,197 4,825 4,706 4,783 5,107 5,989 6,805
Net Debt 1 539 1,162 2,112 18,091 18,660 19,008 18,235 16,920
Reference price 2 825.00 1,003.50 1,006.50 775.80 747.60 926.00 926.00 926.00
Nbr of stocks (in thousands) 212,414 212,677 212,709 212,307 224,660 224,840 - -
Announcement Date 05/11/19 03/11/20 01/11/21 07/11/22 09/11/23 - - -
1DKK in Million2DKK
Estimates

P/E ratio, Detailed evolution

Add to a list
P/E ratio EV / Sales EV / EBITDA Yield (Y) Capi. ($)
40.51x8.38x26.26x+2.17%30.63B
8.33x0.84x3.44x+4.11%2.52B
14.76x - - - 2.52B
18.6x - - +2.66%2.04B
45.16x2.57x20.16x+1.28%1.95B
-55.76x2.7x35.05x-.--%1.69B
14.01x - - - 1.61B
19.45x2.5x9.5x+2.12%1.46B
26.11x3.17x13.08x-.--%1.23B
37.99x1.58x12.62x+1.17%1.1B
Average 16.91x 3.11x 17.16x +1.69% 4.68B
Weighted average by Cap. 31.14x 6.84x 23.54x +2.09%
See all sector valuations

Year-on-year evolution of the PER

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Equities
  3. COLO B Stock
  4. Valuation Coloplast A/S
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW